Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KALA | KALA BIO INC | $3.27M | $0.40 | $32.67 | 8,107.79% | Buy | 3 | N/A | N/A | N/A | N/A | |||
| FBLG | FIBROBIOLOGICS INC | $12.97M | $0.25 | $10.00 | 3,868.25% | Strong Buy | 2 | N/A | N/A | -27,292.30% | -390.16% | |||
| PSTV | PLUS THERAPEUTICS INC | $38.48M | $0.28 | $6.75 | 2,310.71% | Strong Buy | 4 | 105.78% | N/A | 526.98% | 142.66% | |||
| RCKT | ROCKET PHARMACEUTICALS INC | $358.22M | $3.31 | $72.25 | 2,082.78% | Buy | 4 | N/A | N/A | -22.08% | -18.82% | |||
| NRXP | NRX PHARMACEUTICALS INC | $50.58M | $1.80 | $36.75 | 1,941.67% | Strong Buy | 4 | 1,549.32% | N/A | -610.91% | 1,049.22% | |||
| CLGN | COLLPLANT BIOTECHNOLOGIES LTD | $7.26M | $0.63 | $11.50 | 1,713.88% | Strong Buy | 2 | 226.14% | N/A | -2.51% | -1.66% | |||
| NAKA | NAKAMOTO INC | $119.64M | $0.27 | $4.50 | 1,554.41% | Strong Buy | 2 | 1,384.79% | N/A | 0.94% | 0.65% | |||
| OSTX | OS THERAPIES INC | $42.61M | $1.21 | $18.50 | 1,428.93% | Strong Buy | 2 | N/A | N/A | -85.59% | -34.77% | |||
| SLE | SUPER LEAGUE ENTERPRISE INC | $3.38M | $4.02 | $60.00 | 1,392.54% | Strong Buy | 2 | N/A | N/A | N/A | -76.02% | |||
| SGMO | SANGAMO THERAPEUTICS INC | $124.50M | $0.37 | $5.50 | 1,386.49% | Buy | 2 | 89.70% | N/A | 4,425.69% | 311.69% | |||
| TLRY | TILRAY BRANDS INC | $874.97M | $7.51 | $105.00 | 1,298.14% | Buy | 2 | 4.66% | N/A | 5.72% | 4.30% | |||
| GUTS | FRACTYL HEALTH INC | $53.86M | $0.39 | $5.40 | 1,274.05% | Strong Buy | 4 | 3,170.16% | N/A | -205.26% | 5.71% | |||
| PDSB | PDS BIOTECHNOLOGY CORP | $33.21M | $0.68 | $9.00 | 1,227.43% | Strong Buy | 2 | N/A | N/A | 237.82% | 64.78% | |||
| ACET | ADICET BIO INC | $67.43M | $7.04 | $89.00 | 1,164.20% | Strong Buy | 2 | N/A | N/A | 12.23% | 9.50% | |||
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | $30.38M | $0.26 | $3.33 | 1,162.50% | Strong Buy | 6 | N/A | N/A | 1,521.90% | 483.11% | |||
| SNTI | SENTI BIOSCIENCES INC | $22.56M | $0.86 | $10.33 | 1,104.31% | Strong Buy | 3 | N/A | N/A | -549.81% | -84.75% | |||
| ENLV | ENLIVEX THERAPEUTICS LTD | $26.72M | $1.10 | $13.00 | 1,081.82% | Strong Buy | 2 | N/A | N/A | 66.62% | 55.62% | |||
| IFRX | INFLARX NV | $57.52M | $0.85 | $10.00 | 1,077.86% | Buy | 3 | 102.69% | N/A | -29.49% | -20.53% | |||
| TVRD | TVARDI THERAPEUTICS INC | $34.24M | $3.65 | $38.00 | 941.10% | Strong Buy | 2 | -100.00% | N/A | -69.71% | -49.78% | |||
| VNRX | VOLITIONRX LTD | $27.26M | $0.22 | $2.25 | 913.51% | Strong Buy | 2 | 342.92% | N/A | -224.22% | 1,204.23% | |||
| HUMA | HUMACYTE INC | $213.49M | $1.14 | $11.13 | 875.88% | Strong Buy | 4 | 480.57% | N/A | -15,036.89% | 780.69% | |||
| APRE | APREA THERAPEUTICS INC | $3.79M | $0.60 | $5.50 | 816.67% | Buy | 2 | 382.08% | N/A | 40.70% | 31.01% | |||
| PALI | PALISADE BIO INC | $253.31M | $1.70 | $14.67 | 762.76% | Strong Buy | 3 | N/A | N/A | -1,443.18% | -664.78% | |||
| TNYA | TENAYA THERAPEUTICS INC | $105.07M | $0.63 | $5.33 | 745.17% | Strong Buy | 3 | N/A | N/A | 702.97% | 554.90% | |||
| ACRV | ACRIVON THERAPEUTICS INC | $50.49M | $1.60 | $13.50 | 743.75% | Strong Buy | 2 | N/A | N/A | -38.36% | -33.95% | |||
| CTSO | CYTOSORBENTS CORP | $40.19M | $0.64 | $5.38 | 739.84% | Buy | 2 | 33.24% | N/A | N/A | N/A | |||
| RANI | RANI THERAPEUTICS HOLDINGS INC | $155.53M | $1.28 | $10.50 | 720.31% | Strong Buy | 2 | 196.39% | N/A | N/A | -543.98% | |||
| CLNN | CLENE INC | $43.61M | $4.22 | $34.00 | 705.69% | Strong Buy | 3 | 772.06% | N/A | -497.31% | 275.43% | |||
| INTZ | INTRUSION INC | $18.17M | $0.90 | $7.25 | 701.99% | Buy | 2 | N/A | N/A | -65.85% | -47.24% | |||
| CAN | CANAAN INC | $303.00M | $0.46 | $3.55 | 680.22% | Strong Buy | 5 | -6.85% | N/A | 206.57% | 149.86% | |||
| CABA | CABALETTA BIO INC | $284.95M | $2.96 | $23.00 | 677.03% | Strong Buy | 2 | N/A | N/A | -22.76% | -16.73% | |||
| MREO | MEREO BIOPHARMA GROUP PLC | $66.20M | $0.42 | $3.13 | 651.20% | Strong Buy | 4 | 543.25% | N/A | -78.72% | -68.43% | |||
| HELP | CYBIN INC | $337.28M | $6.76 | $49.33 | 629.78% | Strong Buy | 3 | N/A | N/A | -54.95% | -51.89% | |||
| HOWL | WEREWOLF THERAPEUTICS INC | $31.99M | $0.66 | $4.67 | 608.19% | Strong Buy | 3 | N/A | N/A | -216.51% | -80.52% | |||
| TCRX | TSCAN THERAPEUTICS INC | $55.33M | $0.98 | $6.50 | 566.67% | Buy | 2 | 34.41% | N/A | -23.91% | -13.13% | |||
| CRBU | CARIBOU BIOSCIENCES INC | $144.88M | $1.55 | $10.00 | 545.16% | Strong Buy | 3 | 82.86% | N/A | -52.43% | -38.14% | |||
| JSPR | JASPER THERAPEUTICS INC | $33.86M | $1.21 | $7.75 | 540.50% | Buy | 4 | N/A | N/A | -151.71% | -30.55% | |||
| CING | CINGULATE INC | $39.33M | $5.82 | $37.00 | 535.74% | Strong Buy | 2 | N/A | N/A | N/A | N/A | |||
| AUTL | AUTOLUS THERAPEUTICS PLC | $401.88M | $1.51 | $9.50 | 529.14% | Buy | 2 | 100.70% | N/A | 26.50% | 10.63% | |||
| CRVO | CERVOMED INC | $42.01M | $4.54 | $28.00 | 516.74% | Strong Buy | 2 | -42.61% | N/A | -25.64% | -21.79% | |||
| LUNG | PULMONX CORP | $61.46M | $1.49 | $9.00 | 504.03% | Strong Buy | 2 | 19.08% | N/A | 106.87% | 46.40% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.